APAC Cancer Diagnostic Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

May 2017 | 350 pages | ID: AAFEDBB6584EN
Data Bridge Market Research

Abstracts

In this region, APAC Cancer Diagnostics Market is accounted to reach USD 7.10 billion by 2024 from USD 2.70 billion in 2016,it is growing at a CAGR of 12.7% in the forecast period 2017 to 2024

The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries.

The key market players for APAC Cancer Diagnostics Market are listed below:

• Hoffman-La Roche Ltd
• Abbott Laboratories Inc
• QIAGEN.

The market is further segmented into:

• Type
• Application
• Technology
• End User
• Geography

The APAC cancer diagnostics market is segmented on the basis of technology, application and geography. The APAC cancer diagnostics market is segmented into 2 types- platform based and instrument based.

In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Based on geography, the APAC Cancer Diagnostics Market is segmented into 11 geographical regions, such as,

• China,
• Japan,
• India,
• South Korea,
• Australia,
• Thailand,
• Malaysia,
• Singapore,
• Indonesia,
• Philippines
• Rest of APAC

Covered in this report

The report covers the present scenario and the growth prospects of the APAC Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Contents

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF APAC CANCER DIAGNOSTICS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. GROWTH OF AGING POPULATION AND RISING PREVALENCE OF CANCER
  3.1.2. GOVERNMENT INITIATIVES FOR FUNDING AND AWARENESS ABOUT CANCER
  3.1.3. KEY PLAYERS FOCUSING ON STRATEGIC DECISIONS TO GAIN MARKET SHARE
  3.1.4. INCREASING PREVELANCE OF CANCER
3.2. RESTRAINTS
  3.2.1. STRINGENT REULATIONS IMPOSED BY INTERNATIONAL AND LOCAL AUTHORITIES
  3.2.2. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS
3.3. OPPORTUNITIES
  3.3.1. NANOTECHNOLOGY: FORTHCOMING REVOLUTION IN CANCER DIAGNOSIS
  3.3.2. ARTIFICIAL INTELLIGENCE AND THE IMMINENT

HEALTH REVOLUTION

  3.3.3. GROWING MEDICAL TOURISM IN ASIA
3.4. CHALLENGES
  3.4.1. INCREASING RIVALRY AMONG THE COMPETITORS
  3.4.2. POOR ACCESS TO CANCER DETECTION AND HIGH TREATMENT COCTS IN LOWER INCOME COUNTRIES

4. PREMIUM INSIGHTS

5. EXECUTIVE SUMMARY

6. APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY

6.1. OVERVIEW
6.2. PLATFORM BASED
  6.2.1. POLYMERASE CHAIN REACTION(PCR)
  6.2.2. IN SITU HYBRIDIZATION (ISH)
  6.2.3. IMMUNOHISTOCHEMISTRY(IHC)
  6.2.4. NEXT GENERATION SEQUENCING (NGS)
  6.2.5. DNA MICROARRAYS
  6.2.6. FLOW CYTOMETRY
6.3. INSTRUMENT BASED
  6.3.1. IMAGING
    6.3.1.1. MAGENTIC RESONANCE IMAGING (MRI)
    6.3.1.2. CT(COMPUTED TOMOGRAPHY)
    6.3.1.3. POSITRON EMISSION TOMOGRAPHY- COMPUTED TOMOGRAPHY (PET-CT)
    6.3.1.4. MAMMOGRAPHY
    6.3.1.5. ULTRASOUND
  6.3.2. BIOPSY

7. APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION

7.1. OVERVIEW
7.2. LUNG CANCER
7.3. BREAST CANCER
7.4. COLORECTAL CANCER
7.5. MELANOMA
7.6. OTHERS

8. APAC CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY

8.1. OVERVIEW
8.2. APAC CANCER DIAGNOSTICS MARKET
  8.2.1. JAPAN CANCER DIAGNOSTICS MARKET
  8.2.2. CHINA CANCER DIAGNOSTICS MARKET
  8.2.3. INDIA CANCER DIAGNOSTICS MARKET
  8.2.4. SOUTH KOREA CANCER DIAGNOSTICS MARKET
  8.2.5. AUSTRALIA CANCER DIAGNOSTICS MARKET
  8.2.6. THAILAND CANCER DIAGNOSTICS MARKET
  8.2.7. SINGAPORE CANCER DIAGNOSTICS MARKET
  8.2.8. MALAYSIA CANCER DIAGNOSTICS MARKET
  8.2.9. INDONESIA CANCER DIAGNOSTICS MARKET
  8.2.10. PHILIPPINES CANCER DIAGNOSTICS MARKET
  8.2.11. REST OF APAC CANCER DIAGNOSTICS MARKET

9. APAC CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE

9.1. COMPANY SHARE ANALYSIS: APAC CANCER DIAGNOSTICS IMAGING MARKET
9.2. COMPANY SHARE ANALYSIS: APAC CANCER DIAGNOSTICS PLATFORM BASED MARKET

10. COMPANY PROFILES

10.1. C. R. BARD, INC.
  10.1.1. COMPANY OVERVIEW
  10.1.2. REVENUE ANALYSIS
  10.1.3. PRODUCT PORTFOLIO
  10.1.4. RECENT DEVELOPMENTS
10.2. ILLUMINA, INC.
  10.2.1. COMPANY OVERVIEW
  10.2.2. REVENUE ANALYSIS
  10.2.3. RECENT DEVELOPMENTS
  10.2.4. PRODUCT PORTFOLIO
10.3. QIAGEN
  10.3.1. COMPANY OVERVIEW
  10.3.2. REVENUE ANALYSIS
  10.3.3. RECENT DEVELOPMENTS
  10.3.4. PRODUCT PORTFOLIO
10.4. ABBOTT
  10.4.1. COMPANY OVERVIEW
  10.4.2. REVENUE ANALYSIS
  10.4.3. RECENT DEVELOPMENTS
  10.4.4. PRODUCT PORTFOLIO
10.5. SIEMENS HEALTHCARE GMBH
  10.5.1. COMPANY OVERVIEW
  10.5.2. REVENUE ANALYSIS
  10.5.3. RECENT DEVELOPMENTS
  10.5.4. PRODUCT PORTFOLIO
10.6. AGILENT TECHNOLOGIES
  10.6.1. COMPANY OVERVIEW
  10.6.2. REVENUE ANALYSIS
  10.6.3. PRODUCT PORTFOLIO
  10.6.4. RECENT DEVELOPMENTS
10.7. THERMO FISHER SCIENTIFIC INC.
  10.7.1. COMPANY OVERVIEW
  10.7.2. REVENUE ANALYSIS
  10.7.3. PRODUCT PORTFOLIO
  10.7.4. RECENT DEVELOPMENTS
10.8. BECTON, DICKINSON AND COMPANY
  10.8.1. COMPANY OVERVIEW
  10.8.2. REVENUE ANALYSIS
  10.8.3. PRODUCT PORTFOLIO
  10.8.4. RECENT DEVELOPMENTS
10.9. GE HEALTHCARE
  10.9.1. COMPANY OVERVIEW
  10.9.2. REVENUE ANALYSIS
  10.9.3. PRODUCT PORTFOLIO
  10.9.4. RECENT DEVELOPMENTS
10.10. F. HOFFMANN-LA ROCHE LTD
  10.10.1. COMPANY OVERVIEW
  10.10.2. REVENUE ANALYSIS
  10.10.3. PRODUCT PORTFOLIO
  10.10.4. RECENT DEVELOPMENTS
10.11. HOLOGIC INC.
  10.11.1. COMPANY OVERVIEW
  10.11.2. REVENUE ANALYSIS
  10.11.3. RECENT DEVELOPMENTS
  10.11.4. PRODUCT PORTFOLIO
10.12. KONINKLIJHE PHILIPS N.V.
  10.12.1. COMPANY OVERVIEW
  10.12.2. REVENUE ANALYSIS
  10.12.3. PRODUCT PORTFOLIO
  10.12.4. RECENT DEVELOPMENTS

11. RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 2 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 3 APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 4 APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 5 APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 6 APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 7 JAPANCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 8 JAPAN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 9 JAPAN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 10 JAPAN INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 11 JAPAN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 12 CHINA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 13 CHINA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 14 CHINA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 15 CHINA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 16 CHINA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 17 INDIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 18 INDIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 19 INDIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 20 INDIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 21 INDIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 22 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 23 SOUTH KOREA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 24 SOUTH KOREA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 25 SOUTH KOREA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 26 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 27 AUSTRALIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 28 AUSTRALIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 29 AUSTRALIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 30 AUSTRALIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 31 AUSTRALIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 32 THAILAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 33 THAILAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 34 THAILAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 35 THAILAND INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 36 THAILAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 37 SINGAPORE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 38 SINGAPORE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 39 SINGAPORE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 40 SINGAPORE INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 41 SINGAPORE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 42 MALAYSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 43 MALAYSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 44 MALAYSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 45 MALAYSIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 46 MALAYSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 47 INDONESIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 48 INDONESIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 49 INDONESIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 50 INDONESIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 51 INDONESIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 52 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 53 PHILLIPINES PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 54 PHILIPPINES INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 55 PHILIPPINES INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 56 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)
Table 57 REST OF APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
Table 58 REST OF APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 59 REST OF APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
Table 60 REST OF APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION)
Table 61 REST OF APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION)

List Of Figures

LIST OF FIGURES

Figure 1 ASIA-PACIFIC AND SOUTH AMERICA ARE THE HIGHEST GROWING AND MOST PROFITable REVENUE POCKETS FOR CANCER DIAGNOSTICS MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024
Figure 2 APAC CANCER DIAGNOSTICS MARKET : SNAPSHOT (2017)
Figure 3 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY (2016)
Figure 4 APAC CANCER DIAGNOSTICS MARKET : BY COUNTRY (2017)
Figure 5 APAC CANCER DIAGNOSTICS MARKET BY COUNTRY (2016 & 2024)
Figure 6 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY (2017 & 2024)